Mainz Biomed N.V. Ordinary Shares (QUCY)

FairStock Score: 27/100 — RISKY

Key Financials

AI Analysis

AI-generated, general educational analysis — not personal investment advice.

I begin with Graham's question: is this a business with durable earning power and a margin of safety? Based on the filed figures, the answer is no. In fiscal 2025, the year ended 2025-12-31, revenue was $537,080, down from $893,991 in fiscal 2024, the year ended 2024-12-31. That is a nearly 40% decline, not growth. Net losses were $16.2M in fiscal 2025 and $21.6M in fiscal 2024. The most recent filed quarter, fiscal Q2 2026 ended 2026-06-30, showed a net loss of $11.0M, or diluted EPS -$0.62, far worse than fiscal Q1 2026 ended 2026-03-31, with a -$5.1M loss, and fiscal Q2 2025 ended 2025-06-30, with a -$3.5M loss. Losses are accelerating even though revenue is not reported in those quarters. The balance-sheet picture is equally unsettling: FairStock's calculated Altman Z-score is -6.04, its Piotroski score is 2/9, and trailing free cash flow is -$18.0M against a $6.3M market cap. That FCF yield of -286.4% means the company burns cash at a rate that dwarfs its equity value. The low debt-to-equity of 0.01 is a small comfort, but it does not create a moat. The business description points to cybersecurity and quantum computing, markets that may have promise, but there is no evidence here of pricing power, recurring revenue, or competitive protection. At the 2026-10-13 close of $1.12, the P/B is 1.38 and the P/E is -0.46, but those ratios are not meaningful without profits. With only two years of filed results, the Lynch category is none. This is a speculative financing vehicle, not a value investment.

In plain English: The provided profile is inconsistent: the name is Mainz Biomed, but the business description says Quantum Cyber N.V., a cybersecurity and quantum-technology firm. The company is losing money, has very little revenue, and its losses are large compared with its $6.3 million market value. At the 2026-10-13 close of $1.12, the price does not look supported by current profits or cash flow.

The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.

Data as of 2026-10-13 close · note generated 2026-10-15 · model deepseek-flash

Sources (SEC EDGAR): fiscal Q2 2026 10-Q (period ended 2026-06-30) · fiscal Q1 2026 10-Q (period ended 2026-03-31) · fiscal Q2 2025 10-Q (period ended 2025-06-30) · fiscal Q1 2025 10-Q (period ended 2025-03-31) · FY2025 10-K (period ended 2025-12-31) · FY2024 10-K (period ended 2024-12-31)

Fundamentals from company filings and market-data providers; prices are end-of-day, not real-time. AI-generated analysis is general and educational — not personal investment advice. Scoring methodology · Score test · Disclaimer